Making labels comply with MDR
The new European Medical Devices Regulation (MDR) is forcing companies to review their labeling infrastructure as they battle for organisational preparedness
19th June 2018
Web Exclusives
How to double the productivity of your discovery scientists
A modular approach to omics data architecture could give discovery scientists back fifty per cent of their time
18th June 2018
Learning from both success and failure in severe asthma
The NIHR's Professor Chris Brightling explains how negative results from an asthma study can teach us just as much as positive results
15th June 2018
Late to regenerate
Are current regulatory frameworks hindering therapy development for regenerative medicine?
12th June 2018
At the crossroads of engineering and medicine
The current state of the tissue engineering market
11th June 2018
Guilty? Are We?
Graham Kershaw, Managing Director of packaging designers and manufacturers, Macpac, addresses consumer and some media concerns in regard to packaging waste – Guilty? Are We?
4th June 2018
Feeling the pinch
EMIG chairman Leslie Galloway writes about how the fees associated with new regulations on medicines verification are hitting small companies
1st June 2018
Public consultation in healthcare provision: the good, the bad and the unacceptable
Are all healthcare public consultations appraised positively? And if not, why not?
31st May 2018
Building a Key Account Organisation? 5 questions to tell you if you are ready
When an entire business combines forces around its key accounts so that well-informed, value adding, conversations with customers are commonplace, it results in a demonstrable difference in patient care
29th May 2018
3D printing: risks vs. benefits for the pharma industry
3D printing is transforming certain industries - so why hasn't it been widely adopted in the pharma sector?
29th May 2018
Trump’s drug pricing plan: light on details, heavy on questions
How new US plans to lower drug prices and increase competition could affect companies
25th May 2018
Using real world data in drug discovery
Chris Molloy and James Peach from the Medicine Discovery Catapult talk about humanising discovery and real world evidence and improving access for SMEs to the NHS Ecosystem
24th May 2018
Honing submissions resource management
How do life sciences firms measure the efficiency of regulatory submissions management, and what’s the key to improving productivity?
24th May 2018
GDPR: A roadmap to compliance
The steps pharma organisations can take towards GDPR readiness and why the new regulation could be a positive catalyst for change
23rd May 2018
From drug delivery to healthcare delivery
What advances in drug delivery devices are in store for us over the next 20-30 years?
17th May 2018
